About this Journal Submit a Manuscript Table of Contents
Stroke Research and Treatment
Volume 2013 (2013), Article ID 263974, 42 pages
http://dx.doi.org/10.1155/2013/263974
Review Article

Clinical Trials in Cardiac Arrest and Subarachnoid Hemorrhage: Lessons from the Past and Ideas for the Future

Cleveland Clinic Foundation, Neurological Institute, Cerebrovascular Center, Cleveland Clinic, 9500 Euclid Avenue S80, Cleveland, OH 44195, USA

Received 17 December 2012; Accepted 29 January 2013

Academic Editor: R. Loch Macdonald

Copyright © 2013 Jennifer A. Frontera. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Frontera, A. Fernandez, J. M. Schmidt et al., “Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?” Stroke, vol. 40, no. 6, pp. 1963–1968, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. E. Wartenberg, J. M. Schmidt, J. Claassen et al., “Impact of medical complications on outcome after subarachnoid hemorrhage,” Critical Care Medicine, vol. 34, no. 3, pp. 617–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. S. Allen, H. S. Ahn, T. J. Preziosi et al., et al., “Cerebral arterial spasm–a controlled trial of nimodipine in patients with subarachnoid hemorrhage,” The New England Journal of Medicine, vol. 308, no. 11, pp. 619–624, 1983. View at Publisher · View at Google Scholar
  4. K. C. Petruk, M. West, G. Mohr et al., “Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial,” Journal of Neurosurgery, vol. 68, no. 4, pp. 505–517, 1988. View at Scopus
  5. E. Mee, D. Dorrance, D. Lowe, and G. Neil-Dwyer, “Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage,” Neurosurgery, vol. 22, no. 3, pp. 484–491, 1988. View at Scopus
  6. J. D. Pickard, G. D. Murray, R. Illingworth et al., “Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial,” British Medical Journal, vol. 298, no. 6674, pp. 636–642, 1989. View at Scopus
  7. J. M. Gilsbach, H. J. Reulen, B. Ljunggren et al., “Early aneurysm surgery and preventive therapy with intravenously administered nimodipine: a multicenter, double-blind, dose-comparison study,” Neurosurgery, vol. 26, no. 3, pp. 458–464, 1990. View at Scopus
  8. J. Ohman, A. Servo, and O. Heiskanen, “Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery,” Journal of Neurosurgery, vol. 74, no. 1, pp. 8–13, 1991. View at Scopus
  9. V. Soppi, P. N. Karamanakos, T. Koivisto et al., “A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage,” World Neurosurgery, vol. 78, no. 1-2, pp. 101–109, 2012. View at Publisher · View at Google Scholar
  10. E. C. Haley Jr., N. F. Kassell, and J. C. Torner, “A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the cooperative aneurysm study,” Journal of Neurosurgery, vol. 78, no. 4, pp. 548–553, 1993. View at Scopus
  11. E. C. Haley Jr., N. F. Kassell, and J. C. Torner, “A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study,” Journal of Neurosurgery, vol. 78, no. 4, pp. 537–547, 1993. View at Scopus
  12. E. C. Haley Jr., N. F. Kassell, J. C. Torner, L. L. Truskowski, and T. P. Germanson, “A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage: a report of the cooperative aneurysm study,” Journal of Neurosurgery, vol. 80, no. 5, pp. 788–796, 1994. View at Scopus
  13. M. Barth, H. H. Capelle, S. Weidauer et al., “Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study,” Stroke, vol. 38, no. 2, pp. 330–336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Fodstad, A. Forssell, B. Liliequist, and M. Schannong, “Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial,” Neurosurgery, vol. 8, no. 2, pp. 158–165, 1981. View at Scopus
  15. U. M. Chowdhary and K. Sayed, “Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 44, no. 9, pp. 810–813, 1981. View at Publisher · View at Google Scholar
  16. M. Vermeulen, K. W. Lindsay, G. D. Murray et al., et al., “Antifibrinolytic treatment in subarachnoid hemorrhage,” The New England Journal of Medicine, vol. 311, no. 7, pp. 432–437, 1984. View at Publisher · View at Google Scholar
  17. Y. Roos, “Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group,” Neurology, vol. 54, no. 1, pp. 77–82, 2000.
  18. J. Hillman, S. Fridriksson, O. Nilsson, Z. Yu, H. Säveland, and K. E. Jakobsson, “Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study,” Journal of Neurosurgery, vol. 97, no. 4, pp. 771–778, 2002. View at Scopus
  19. I. Saito, T. Asano, and C. Ochiai, “A double-blind clinical evaluation of the effect of nizofenone (Y-9179) on delayed ischemic neurological deficits following aneurysmal rupture,” Neurological Research, vol. 5, no. 4, pp. 29–47, 1983. View at Scopus
  20. T. Ohta, H. Kikuchi, K. Hashi, and Y. Kudo, “Nizofenone administration in the acute stage following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study,” Journal of Neurosurgery, vol. 64, no. 3, pp. 420–426, 1986. View at Scopus
  21. A. Munakata, H. Ohkuma, T. Nakano, N. Shimamura, K. Asano, and M. Naraoka, “Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 64, no. 3, pp. 423–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Yoneda, S. Shirao, J. Nakagawara, K. Ogasawara, T. Tominaga, and M. Suzuki, “A prospective, multicenter, randomized study of the efficacy of eicosapentaenoic acid for cerebral vasospasm: the EVAS study,” World Neurosurgery, 2012. View at Publisher · View at Google Scholar
  23. M. D. Hill, R. H. Martin, D. Mikulis et al., et al., “Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial,” The Lancet Neurology, vol. 11, no. 11, pp. 942–950, 2012. View at Publisher · View at Google Scholar
  24. J. R. Lynch, H. Wang, M. J. McGirt et al., “Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial,” Stroke, vol. 36, no. 9, pp. 2024–2026, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Y. Tseng, M. Czosnyka, H. Richards, J. D. Pickard, and P. J. Kirkpatrick, “Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial,” Stroke, vol. 36, no. 8, pp. 1627–1632, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. S. H. Y. Chou, E. E. Smith, N. Badjatia et al., “A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage,” Stroke, vol. 39, no. 10, pp. 2891–2893, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. D. Vergouwen, J. C. Meijers, R. B. Geskus et al., “Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 8, pp. 1444–1453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Ohman and O. Heiskanen, “Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study,” Journal of Neurosurgery, vol. 70, no. 1, pp. 55–60, 1989. View at Scopus
  29. A. Molyneux, R. Kerr, I. Stratton et al., “International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial,” The Lancet, vol. 360, no. 9342, pp. 1267–1274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Molyneux, R. S. Kerr, L. M. Yu et al., “International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion,” The Lancet, vol. 366, no. 9488, pp. 809–817, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. C. G. McDougall, R. F. Spetzler, J. M. Zabramski et al., “The barrow ruptured aneurysm trial,” Journal of Neurosurgery, vol. 116, no. 1, pp. 135–144, 2012. View at Publisher · View at Google Scholar
  32. N. F. Kassell, E. C. Haley Jr., C. Apperson-Hansen, and W. M. Alves, “Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand,” Journal of Neurosurgery, vol. 84, no. 2, pp. 221–228, 1996. View at Scopus
  33. E. C. Haley Jr., N. F. Kassell, C. Apperson-Hansen, M. H. Maile, and W. M. Alves, “A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America,” Journal of Neurosurgery, vol. 86, no. 3, pp. 467–474, 1997. View at Scopus
  34. G. Lanzino, N. F. Kassell, N. W. C. Dorsch et al., “Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage—part I: a cooperative study in Europe, Australia, New Zealand, and South Africa,” Journal of Neurosurgery, vol. 90, no. 6, pp. 1011–1017, 1999. View at Scopus
  35. G. Lanzino and N. F. Kassell, “Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage—part II: a cooperative study in North America,” Journal of Neurosurgery, vol. 90, no. 6, pp. 1018–1024, 1999. View at Scopus
  36. V. Seifert, D. Stolke, M. Zimmermann, and A. Feldges, “Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study,” Acta Neurochirurgica, vol. 128, no. 1–4, pp. 137–143, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Findlay, “A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm,” Neurosurgery, vol. 37, no. 5, pp. 1026–1027, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Yamamoto, T. Esaki, Y. Nakao, and K. Mori, “Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage,” World Neurosurgery, vol. 73, no. 6, pp. 675–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M. D. Shaw, P. M. Foy, M. Conway et al., “Dipyridamole and postoperative ischemic deficits in aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 63, no. 5, pp. 699–703, 1985. View at Publisher · View at Google Scholar
  40. W. M. van den Bergh, A. Algra, S. M. D. Mees, F. van Kooten, C. M. Dirven, J. van Gijn, et al., “Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH study,” Stroke, vol. 37, no. 9, pp. 2326–2330, 2006. View at Publisher · View at Google Scholar
  41. S. Suzuki, T. Sayama, T. Nakamura et al., “Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report,” Cerebrovascular Diseases, vol. 32, no. 1, pp. 89–93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Hasan, K. W. Lindsay, E. F. M. Wijdicks et al., “Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage,” Stroke, vol. 20, no. 9, pp. 1156–1161, 1989. View at Scopus
  43. Y. Katayama, J. Haraoka, H. Hirabayashi et al., “A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage,” Stroke, vol. 38, no. 8, pp. 2373–2375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Gomis, J. P. Graftieaux, R. Sercombe, D. Hettler, B. Scherpereel, and P. Rousseaux, “Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 112, no. 3, pp. 681–688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Y. Tseng, P. J. Hutchinson, H. K. Richards et al., “Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial: clinical article,” Journal of Neurosurgery, vol. 111, no. 1, pp. 171–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. M. Naidech, A. Shaibani, R. K. Garg et al., “Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage,” Neurocritical Care, vol. 13, no. 3, pp. 313–320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. J. I. Suarez, R. H. Martin, E. Calvillo et al., et al., “The albumin in subarachnoid hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes,” Stroke, vol. 43, no. 3, pp. 683–690, 2012. View at Publisher · View at Google Scholar
  48. B. A. Bell, “Effect of calcitonin-gene-related peptide in patients with delayed postoperative cerebral ischaemia after aneurysmal subarachnoid haemorrhage,” The Lancet, vol. 339, no. 8797, pp. 831–834, 1992. View at Scopus
  49. R. L. Macdonald, R. T. Higashida, E. Keller et al., “Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2),” The Lancet Neurology, vol. 10, no. 7, pp. 618–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. R. L. Macdonald, R. T. Higashida, E. Keller et al., et al., “Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling,” Stroke, vol. 43, no. 6, pp. 1463–1469, 2012. View at Publisher · View at Google Scholar
  51. L. Lennihan, S. A. Mayer, M. E. Fink et al., “Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial,” Stroke, vol. 31, no. 2, pp. 383–391, 2000. View at Scopus
  52. A. Egge, K. Waterloo, H. Sjøholm, T. Solberg, T. Ingebrigtsen, and B. Romner, “Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study,” Neurosurgery, vol. 49, no. 3, pp. 593–606, 2001. View at Scopus
  53. G. K. C. Wong, W. S. Poon, M. T. V. Chan et al., “Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial,” Stroke, vol. 41, no. 5, pp. 921–926, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. S. M. D. Mees, A. Algra, W. P. Vandertop et al., et al., “Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial,” The Lancet, vol. 380, no. 9836, pp. 44–49, 2012.
  55. P. Walter, G. Neil-Dwyer, and J. M. Cruickshank, “Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage,” The British Medical Journal, vol. 284, no. 6330, pp. 1661–1664, 1982. View at Publisher · View at Google Scholar
  56. M. Zwienenberg-Lee, J. Hartman, N. Rudisill et al., “Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with fisher grade IIi subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial,” Stroke, vol. 39, no. 6, pp. 1759–1765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Shibuya, Y. Suzuki, K. Sugita et al., “Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: results of a prospective placebo-controlled double-blind trial,” Journal of Neurosurgery, vol. 76, no. 4, pp. 571–577, 1992. View at Scopus
  58. J. Zhao, D. Zhou, J. Guo et al., et al., “Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine,” Neurologia Medico-Chirurgica, vol. 51, no. 10, pp. 679–683, 2011. View at Publisher · View at Google Scholar
  59. F. Bilotta, A. Spinelli, F. Giovannini, A. Doronzio, R. Delfini, and G. Rosa, “The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial,” Journal of Neurosurgical Anesthesiology, vol. 19, no. 3, pp. 156–160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. M. M. Todd, B. J. Hindman, W. R. Clarke, and J. C. Torner, “Mild intraoperative hypothermia during surgery for intracranial aneurysm,” The New England Journal of Medicine, vol. 352, no. 2, pp. 135–145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. E. Grote and W. Hassler, “The critical first minutes after subarachnoid hemorrhage,” Neurosurgery, vol. 22, no. 4, pp. 654–661, 1988. View at Scopus
  62. F. A. Sehba, G. Mostafa, V. Friedrich Jr., and J. B. Bederson, “Acute microvascular platelet aggregation after subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 102, no. 6, pp. 1094–1100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. F. A. Sehba and J. B. Bederson, “Mechanisms of acute brain injury after subarachnoid hemorrhage,” Neurological Research, vol. 28, no. 4, pp. 381–398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Forsman, H. P. Aarseth, H. K. Nordby, A. Skulberg, and P. A. Steen, “Effects of nimodipine on cerebral blood flow and cerebrospinal fluid pressure after cardiac arrest: correlation with neurologic outcome,” Anesthesia and Analgesia, vol. 68, no. 4, pp. 436–443, 1989. View at Scopus
  65. R. O. Roine, S. Kajaste, and M. Kaste, “Neuropsychological sequelae of cardiac arrest,” The Journal of the American Medical Association, vol. 269, no. 2, pp. 237–242, 1992. View at Publisher · View at Google Scholar · View at Scopus
  66. Brain Resuscitation Clinical Trial II Study Group, “A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest,” The New England Journal of Medicine, vol. 324, no. 18, pp. 1225–1231, 1991.
  67. R. O. Roine, M. Kaste, A. Kinnunen, P. Nikki, S. Sarna, and S. Kajaste, “Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial,” The Journal of the American Medical Association, vol. 264, no. 24, pp. 3171–3177, 1990. View at Publisher · View at Google Scholar · View at Scopus
  68. M. S. Damian, D. Ellenberg, R. Gildemeister et al., “Coenzyme Q10 combined with mild hypothermia after cardiac arrest: a preliminary study,” Circulation, vol. 110, no. 19, pp. 3011–3016, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. D. M. Fatovich, G. J. Dobb, and R. A. Clugston, “A pilot randomised trial of thrombolysis in cardiac arrest (the TICA trial),” Resuscitation, vol. 61, no. 3, pp. 309–313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. B. W. Böttiger, H. R. Arntz, D. A. Chamberlain et al., “Thrombolysis during resuscitation for out-of-hospital cardiac arrest,” The New England Journal of Medicine, vol. 359, no. 25, pp. 2651–2662, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. S. D. Mentzelopoulos, S. G. Zakynthinos, M. Tzoufi et al., “Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest,” Archives of Internal Medicine, vol. 169, no. 1, pp. 15–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. C. G. Brown, D. R. Martin, P. E. Pepe et al., et al., “A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The multicenter high-dose epinephrine study group,” The New England Journal of Medicine, vol. 327, no. 15, pp. 1051–1055, 1992. View at Publisher · View at Google Scholar
  73. C. Choux, P. Y. Gueugniaud, A. Barbieux et al., “Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital,” Resuscitation, vol. 29, no. 1, pp. 3–9, 1995. View at Publisher · View at Google Scholar · View at Scopus
  74. W. D. Patrick, J. Freedman, T. McEwen, R. B. Light, L. Ludwig, and D. Roberts, “A randomized, double-blind comparison of methoxamine and epinephrine in human cardiopulmonary arrest,” The American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 2, pp. 519–523, 1995. View at Scopus
  75. K. H. Lindner, B. Dirks, H. U. Strohmenger, A. W. Prengel, I. M. Lindner, and K. G. Lurie, “Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation,” The Lancet, vol. 349, no. 9051, pp. 535–537, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. B. W. Sherman, M. A. Munger, G. E. Foulke, W. F. Rutherford, and E. A. Panacek, “High-dose versus standard-dose epinephrine treatment of cardiac arrest after failure of standard therapy,” Pharmacotherapy, vol. 17, no. 2, pp. 242–247, 1997. View at Scopus
  77. P. Y. Gueugniaud, P. Mols, P. Goldstein et al., “A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital,” The New England Journal of Medicine, vol. 339, no. 22, pp. 1595–1601, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. I. G. Stiell, P. C. Hébert, G. A. Wells et al., “Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial,” The Lancet, vol. 358, no. 9276, pp. 105–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  79. V. Wenzel, A. C. Krismer, H. R. Arntz, H. Sitter, K. H. Stadlbauer, and K. H. Lindner, “A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation,” The New England Journal of Medicine, vol. 350, no. 2, pp. 105–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. P. Y. Gueugniaud, J. S. David, E. Chanzy et al., et al., “Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation,” The New England Journal of Medicine, vol. 359, no. 1, pp. 21–30, 2008. View at Publisher · View at Google Scholar
  81. M. C. Thel, A. L. Armstrong, S. E. McNulty, R. M. Califf, and C. M. O'Connor, “Randomised trial of magnesium in in-hospital cardiac arrest,” The Lancet, vol. 350, no. 9087, pp. 1272–1276, 1997. View at Publisher · View at Google Scholar · View at Scopus
  82. D. M. Fatovich, D. A. Prentice, and G. J. Dobb, “Magnesium in cardiac arrest (the magic trial),” Resuscitation, vol. 35, no. 3, pp. 237–241, 1997. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Allegra, R. Lavery, R. Cody et al., “Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting,” Resuscitation, vol. 49, no. 3, pp. 245–249, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. T. B. Hassan, C. Jagger, and D. B. Barnett, “A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation,” Emergency Medicine Journal, vol. 19, no. 1, pp. 57–62, 2002. View at Scopus
  85. W. T. Longstreth Jr., C. E. Fahrenbruch, M. Olsufka, T. R. Walsh, M. K. Copass, and L. A. Cobb, “Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest,” Neurology, vol. 59, no. 4, pp. 506–514, 2002. View at Scopus
  86. W. T. Longstreth Jr., M. K. Copass, L. K. Dennis, M. E. Rauch-Matthews, M. S. Stark, and L. A. Cobb, “Intravenous glucose after out-of-hospital cardiopulmonary arrest: a community-based randomized trial,” Neurology, vol. 43, no. 12 I, pp. 2534–2541, 1993. View at Scopus
  87. T. Oksanen, M. B. Skrifvars, T. Varpula et al., “Strict versus moderate glucose control after resuscitation from ventricular fibrillation,” Intensive Care Medicine, vol. 33, no. 12, pp. 2093–2100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. S. A. Bernard, T. W. Gray, M. D. Buist et al., “Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia,” The New England Journal of Medicine, vol. 346, no. 8, pp. 557–563, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. The Hypothermia after Cardiac Arrest Study Group, “Mild therapeutic hypothermia to improvethe neurologic outcome after cardiac arrest,” The New England Journal of Medicine, vol. 346, no. 8, pp. 549–556, 2002. View at Publisher · View at Google Scholar
  90. F. Kim, M. Olsufka, W. T. Longstreth Jr. et al., “Pilot randomized clinical trial of prehospital induction of mild hypothermia in out-of-hospital cardiac arrest patients with a rapid infusion of 4 °C normal saline,” Circulation, vol. 115, no. 24, pp. 3064–3070, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. A. KÄmÄrÄinen, I. Virkkunen, J. Tenhunen, A. Yli-Hankala, and T. Silfvast, “Prehospital therapeutic hypothermia for comatose survivors of cardiac arrest: a randomized controlled trial,” Acta Anaesthesiologica Scandinavica, vol. 53, no. 7, pp. 900–907, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Castrén, P. Nordberg, L. Svensson et al., “Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: pre-ROSCintraNasal cooling effectiveness),” Circulation, vol. 122, no. 7, pp. 729–736, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. T. J. Cohen, B. G. Goldner, P. C. Maccaro et al., “A comparison of active compression-decompression cardiopulmonary resuscitation with standard cardiopulmonary resuscitation for cardiac arrests occurring in the hospital,” The New England Journal of Medicine, vol. 329, no. 26, pp. 1918–1921, 1993. View at Publisher · View at Google Scholar · View at Scopus
  94. I. G. Stiell, P. C. Hébert, G. A. Wells et al., “The Ontario trial of active compression-decompression cardiopulmonary resuscitation for in-hospital and prehospital cardiac arrest,” The Journal of the American Medical Association, vol. 275, no. 18, pp. 1417–1423, 1996. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Hallstrom, L. Cobb, E. Johnson, and M. Copass, “Cardiopulmonary resuscitation by chest compression alone or with mouth-to-mouth ventilation,” The New England Journal of Medicine, vol. 342, no. 21, pp. 1546–1553, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. C. Bertrand, F. Hemery, P. Carli et al., “Constant flow insufflation of oxygen as the sole mode of ventilation during out-of-hospital cardiac arrest,” Intensive Care Medicine, vol. 32, no. 6, pp. 843–851, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. L. Svensson, K. Bohm, M. Castrèn et al., “Compression-only CPR or standard CPR in out-of-hospital cardiac arrest,” The New England Journal of Medicine, vol. 363, no. 5, pp. 434–442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. T. D. Rea, C. Fahrenbruch, L. Culley et al., “CPR with chest compression alone or with rescue breathing,” The New England Journal of Medicine, vol. 363, no. 5, pp. 423–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. T. P. Aufderheide, G. Nichol, T. D. Rea et al., et al., “A trial of an impedance threshold device in out-of-hospital cardiac arrest,” The New England Journal of Medicine, vol. 365, no. 9, pp. 798–806, 2011. View at Publisher · View at Google Scholar
  100. R. B. Abu-Laban, C. M. McIntyre, J. M. Christenson et al., “Aminophylline in bradyasystolic cardiac arrest: a randomised placebo-controlled trial,” The Lancet, vol. 367, no. 9522, pp. 1577–1584, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. B. E. Heradstveit, A. B. Guttormsen, J. Langorgen et al., et al., “Capillary leakage in post-cardiac arrest survivors during therapeutic hypothermia—a prospective, randomised study,” Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, vol. 18, article 29, 2010. View at Publisher · View at Google Scholar
  102. Brain Resuscitation Clinical Trial I Study Group, “Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest,” The New England Journal of Medicine, vol. 314, no. 7, pp. 397–403, 1986.
  103. H. A. Stueven, B. M. Thompson, C. Aprahamian, and D. J. Tonsfeldt, “Calcium chloride: reassessment of use in asystole,” Annals of Emergency Medicine, vol. 13, no. 9, pp. 820–822, 1984. View at Scopus
  104. H. A. Stueven, B. Thompson, C. Aprahamian, D. J. Tonsfeldt, and E. H. Kastenson, “The effectiveness of calcium chloride in refractory electromechanical dissociation,” Annals of Emergency Medicine, vol. 14, no. 7, pp. 626–629, 1985. View at Scopus
  105. H. A. Stueven, B. Thompson, C. Aprahamian, D. J. Tonsfeldt, and E. H. Kastenson, “Lack of effectiveness of calcium chloride in refractory asystole,” Annals of Emergency Medicine, vol. 14, no. 7, pp. 630–632, 1985. View at Scopus
  106. T. Dybvik, T. Strand, and P. A. Steen, “Buffer therapy during out-of-hospital cardiopulmonary resuscitation,” Resuscitation, vol. 29, no. 2, pp. 89–95, 1995. View at Publisher · View at Google Scholar · View at Scopus
  107. R. B. Vukmir and L. Katz, “Sodium bicarbonate improves outcome in prolonged prehospital cardiac arrest,” American Journal of Emergency Medicine, vol. 24, no. 2, pp. 156–161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. I. Laurent, C. Adrie, C. Vinsonneau et al., “High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study,” Journal of the American College of Cardiology, vol. 46, no. 3, pp. 432–437, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. I. G. Stiell, G. Nichol, B. G. Leroux et al., et al., “Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest,” The New England Journal of Medicine, vol. 365, no. 9, pp. 787–797, 2011. View at Publisher · View at Google Scholar
  110. G. S. Allen, H. S. Ahn, T. J. Preziosi et al., et al., “Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage,” The New England Journal of Medicine, vol. 308, no. 11, pp. 619–624, 1983. View at Scopus
  111. S. M. D. Mees, G. J. E. Rinkel, V. L. Feigin et al., “Calcium antagonists for aneurysmal subarachnoid hemorrhage,” Stroke, vol. 39, no. 2, pp. 514–515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. Y. B. W. E. M. Roos, M. Levi, T. A. Carroll, L. F. M. Beenen, and M. Vermeulen, “Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage,” Stroke, vol. 32, no. 8, pp. 1860–1862, 2001. View at Scopus
  113. J. P. Dreier, K. Körner, N. Ebert et al., “Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space,” Journal of Cerebral Blood Flow and Metabolism, vol. 18, no. 9, pp. 978–990, 1998. View at Scopus
  114. M. D. Vergouwen, A. Algra, and G. J. Rinkel, “Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update,” Stroke, vol. 43, no. 10, pp. 2671–2676, 2012. View at Publisher · View at Google Scholar
  115. X. Wang, Y. M. Li, W. Q. Li, C. G. Huang, Y. C. Lu, and L. J. Hou, “Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials,” PloS ONE, vol. 7, no. 10, Article ID e47778, 2012.
  116. R. W. Crowley, R. Medel, A. S. Dumont et al., et al., “Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage,” Stroke, vol. 42, no. 4, pp. 919–923, 2011. View at Publisher · View at Google Scholar
  117. J. Mocco, E. R. Ransom, R. J. Komotar et al., “Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 59, no. 3, pp. 529–538, 2006. View at Publisher · View at Google Scholar · View at Scopus